Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 32

1.

Molecular characterization of a neutralizing domain of the Japanese encephalitis virus structural glycoprotein.

Mason PW, Dalrymple JM, Gentry MK, McCown JM, Hoke CH, Burke DS, Fournier MJ, Mason TL.

J Gen Virol. 1989 Aug;70 ( Pt 8):2037-49.

PMID:
2549181
2.

Identification of an antigenic and genetic variant of dengue-4 virus from the Caribbean.

Henchal EA, Repik PM, McCown JM, Brandt WE.

Am J Trop Med Hyg. 1986 Mar;35(2):393-400.

PMID:
3513650
3.

Epitopic analysis of antigenic determinants on the surface of dengue-2 virions using monoclonal antibodies.

Henchal EA, McCown JM, Burke DS, Seguin MC, Brandt WE.

Am J Trop Med Hyg. 1985 Jan;34(1):162-9.

PMID:
2578750
4.

Dengue 2 vaccine: dose response in volunteers in relation to yellow fever immune status.

Scott RM, Eckels KH, Bancroft WH, Summers PL, McCown JM, Anderson JH, Russell PK.

J Infect Dis. 1983 Dec;148(6):1055-60.

PMID:
6655288
5.

RNA fingerprinting as a method for distinguishing dengue 1 virus strains.

Repik PM, Dalrymple JM, Brandt WE, McCown JM, Russell PK.

Am J Trop Med Hyg. 1983 May;32(3):577-89.

PMID:
6859403
6.

Rapid identification of dengue virus isolates by using monoclonal antibodies in an indirect immunofluorescence assay.

Henchal EA, McCown JM, Seguin MC, Gentry MK, Brandt WE.

Am J Trop Med Hyg. 1983 Jan;32(1):164-9.

PMID:
6401944
7.

Dengue-2 vaccine: infection of Aedes aegypti mosquitoes by feeding on viremic recipients.

Bancroft WH, Scott RM, Brandt WE, McCown JM, Eckels KH, Hayes DE, Gould DJ, Russell PK.

Am J Trop Med Hyg. 1982 Nov;31(6):1229-31.

PMID:
7149107
8.

Dengue virus-specific and flavivirus group determinants identified with monoclonal antibodies by indirect immunofluorescence.

Henchal EA, Gentry MK, McCown JM, Brandt WE.

Am J Trop Med Hyg. 1982 Jul;31(4):830-6.

PMID:
6285749
9.
10.

Identification of distinct antigenic determinants on dengue-2 virus using monoclonal antibodies.

Gentry MK, Henchal EA, McCown JM, Brandt WE, Dalrymple JM.

Am J Trop Med Hyg. 1982 May;31(3 Pt 1):548-55.

PMID:
6177259
12.

Dengue in Jamaica.

Bancroft WH, Brandt WE, McCown JM, Russell PK.

Am J Trop Med Hyg. 1981 Mar;30(2):506-7. No abstract available.

PMID:
7235138
13.

Dengue-2 vaccine: virological, immunological, and clinical responses of six yellow fever-immune recipients.

Bancroft WH, Top FH Jr, Eckels KH, Anderson JH Jr, McCown JM, Russell PK.

Infect Immun. 1981 Feb;31(2):698-703.

14.

Effect of passage history on dengue-2 virus replication in subpopulations of human leukocytes.

Brandt WE, McCown JM, Top FH Jr, Bancroft WH, Russell PK.

Infect Immun. 1979 Nov;26(2):534-41.

15.

Dimethyl sulfoxide enhancement of phlebotomus fever virus plaque formation.

McCown JM, Brandt WE, Bancroft WH, Russell PK.

Am J Trop Med Hyg. 1979 Jul;28(4):733-9.

PMID:
223461
16.

Isolation of a temperature-sensitive dengue-2 virus under conditions suitable for vaccine development.

Eckels KH, Brandt WE, Harrison VR, McCown JM, Russell PK.

Infect Immun. 1976 Nov;14(5):1221-7.

17.

Recovery of dengue-2 virus from Aedes aegypti in Colombia.

Morales A, Groot H, Russell PK, McCown JM.

Am J Trop Med Hyg. 1973 Nov;22(6):785-7. No abstract available.

PMID:
4745238
18.

Human immunoglobulin specificity after group B arbovirus infections.

Scott RM, McCown JM, Russell PK.

Infect Immun. 1972 Sep;6(3):277-81.

19.
20.

Comparison of dengue-2 and dengue-3 virus strains by neutralization tests and identification of a subtype of dengue-3.

Russell PK, McCown JM.

Am J Trop Med Hyg. 1972 Jan;21(2):97-9. No abstract available.

PMID:
5061690
21.

Experimental respiratory infection with type 4 adenovirus vaccine in volunteers: clinical and immunological responses.

Smith TJ, Buescher EL, Top FH Jr, Altemeier WA, McCown JM.

J Infect Dis. 1970 Oct;122(4):239-48. No abstract available.

PMID:
4323443
22.

Physical and biological properties of dengue-2 virus and associated antigens.

Smith TJ, Brandt WE, Swanson JL, McCown JM, Buescher EL.

J Virol. 1970 Apr;5(4):524-32.

23.

Recovery of dengue viruses from patients during epidemics in Puerto Rico and East Pakistan.

Russell PK, Buescher EL, McCown JM, Ord├Ánez J.

Am J Trop Med Hyg. 1966 Jul;15(4):573-9. No abstract available.

PMID:
4957424
24.

Challenge virus resistance and interferon produced in BS-C-1 cells by dengue virus.

Russell PK, Bellanti JA, Buescher EL, McCown JM.

Proc Soc Exp Biol Med. 1966 Jun;122(2):557-61. No abstract available.

PMID:
4292463
25.

Report of dengue vaccine field trial in the Caribbean, 1963: a collaborative study.

Bellanti JA, Bourke AT, Buescher EL, Cadigan FC, Cole GA, El Batawi Y, Hatgi JN, McCown JM, Negron H, Ordonez JV, Scheider FG, Smith T, Warram JH, Wisseman CL.

Bull World Health Organ. 1966;35(1):93. No abstract available.

26.

STUDIES OF RUBELLA. II. NEUTRALIZATION OF THE VIRUS.

PARKMAN PD, MUNDON FK, MCCOWN JM, BUESCHER EL.

J Immunol. 1964 Oct;93:608-17. No abstract available.

PMID:
14219076
27.

STUDIES OF RUBELLA. I. PROPERTIES OF THE VIRUS.

PARKMAN PD, BUESCHER EL, ARTENSTEIN MS, MCCOWN JM, MUNDON FK, DRUZD AD.

J Immunol. 1964 Oct;93:595-607. No abstract available.

PMID:
14219075
28.

Vaccination against smallpox. II. Jet injection of chorio-allantoic membrane vaccine.

ELISBERG BL, MCCOWN JM, SMADEL JE.

J Immunol. 1956 Nov;77(5):340-51. No abstract available.

PMID:
13385503
29.

Natural occurrence in dog serum of antibodies against mumps virus.

MORRIS JA, BLOUNT RE, MCCOWN JM.

Cornell Vet. 1956 Oct;46(4):525-31. No abstract available.

30.

Ascites and hepatosplenomegaly in mice associated with protozoan-like cytoplasmic structures.

MORRIS JA, MCCOWN JM, BLOUNT RE.

J Infect Dis. 1956 May-Jun;98(3):306-11. No abstract available.

PMID:
13346126
31.

Serological evidence of toxoplasmosis in animals.

MORRIS JA, AULISIO CG, MCCOWN JM.

J Infect Dis. 1956 Jan-Feb;98(1):52-4. No abstract available.

PMID:
13295625
32.

A complement-fixation test for canine distemper.

MORRIS JA, AULISIO CG, McCOWN JM.

Cornell Vet. 1955 Apr;45(2):182-9. No abstract available.

Supplemental Content

Loading ...
Support Center